Search Results

Identification of patients at risk of ischemic events for long-term secondary prevention

Author: Brassard, Andrea

Source: Journal of the American Academy of Nurse Practitioners, Volume 21, Number 12, December 2009 , pp. 677-689(13)

Publisher: Blackwell Publishing

Dynamic Role of Microparticles in Type 2 Diabetes Mellitus

Author: Nomura, Shosaku

Source: Current Diabetes Reviews, Volume 5, Number 4, November 2009 , pp. 245-251(7)

Publisher: Bentham Science Publishers

Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome

Author: Yakubov, Steven

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2631-2641(11)

Publisher: Informa Healthcare

Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

Authors: FOLSOM, A. R.; OHIRA, T.; YAMAGISHI, K.; CUSHMAN, M.

Source: Journal of Thrombosis and Haemostasis, Volume 7, Number 11, November 2009 , pp. 1774-1778(5)

Publisher: Blackwell Publishing

P-selectin antagonism reduces thrombus formation in humans

Authors: CHELLIAH, R.; LUCKING, A. J.; TATTERSALL, L.; DAGA, S.; BERESFORD-CLEARY, N. J.; CORTAS, K.; FOX, K. A. A.; FEUERSTEIN, G. Z.; CONNOLLY, T. M.; NEWBY, D. E.

Source: Journal of Thrombosis and Haemostasis, Volume 7, Number 11, November 2009 , pp. 1915-1919(5)

Publisher: Blackwell Publishing

A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis

Authors: Hua, Susan; Song, Changjie; Geczy, Carolyn L.; Freedman, S. Ben; Witting, Paul K.

Source: Redox Report, Volume 14, Number 5, October 2009 , pp. 187-196(10)

Publisher: Maney Publishing

Role of Prasugrel, a Novel P2Y₁₂ Receptor Antagonist, in the Management of Acute Coronary Syndromes

Authors: Baker, William L.; White, C. Michael

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 4, 1 August 2009 , pp. 213-229(17)

Publisher: Adis International

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

Authors: Ling, Geoffrey; Ovbiagele, Bruce

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 3, 22 May 2009 , pp. 197-209(13)

Publisher: Adis International

Platelet hyperreactivity, scavenger receptors and atherothrombosis

Authors: VALIYAVEETTIL, M.; PODREZ, E. A.

Source: Journal of Thrombosis and Haemostasis, Volume 7, Supplement 1, July 2009 , pp. 218-221(4)

Publisher: Blackwell Publishing

The translational therapeutics of prostaglandin inhibition in atherothrombosis

Authors: YU, Y.; RICCIOTTI, E.; GROSSER, T.; FITZGERALD, G. A.

Source: Journal of Thrombosis and Haemostasis, Volume 7, Supplement 1, July 2009 , pp. 222-226(5)

Publisher: Blackwell Publishing

Aspirin, 110 years later

Authors: PATRONO, C.; ROCCA, B.

Source: Journal of Thrombosis and Haemostasis, Volume 7, Supplement 1, July 2009 , pp. 258-261(4)

Publisher: Blackwell Publishing

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)

Author: RIDKER, PAUL M.

Source: Journal of Thrombosis and Haemostasis, Volume 7, Supplement 1, July 2009 , pp. 332-339(8)

Publisher: Blackwell Publishing

High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH registry

Authors: Aichner, F. T.; Topakian, R.; Alberts, M. J.; Bhatt, D. L.; Haring, H.-P.; Hill, M. D.; Montalescot, G.; Goto, S.; Touzé, E.; Mas, J.-L.; Steg, P. G.; Röther, J.

Source: European Journal of Neurology, Volume 16, Number 8, August 2009 , pp. 902-908(7)

Publisher: Blackwell Publishing

Adipocytokines and risk of stroke in older people: a nested case-control study

Authors: Stott, David J; Welsh, Paul; Rumley, Ann; Robertson, Michele; Ford, Ian; Sattar, Naveed; Westendorp, Rudi G J; Jukema, J Wouter; Cobbe, Stuart M; Lowe, Gordon D O

Source: International Journal of Epidemiology, Volume 38, Number 1, 25 February 2009 , pp. 253-261(9)

Publisher: Oxford University Press

The Important New Drug Target in Cardiovascular Medicine - the Vascular Glycocalyx

Authors: Drake-Holland, Angela J.; Noble, Mark I.

Source: Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current D, Volume 9, Number 2, June 2009 , pp. 118-123(6)

Publisher: Bentham Science Publishers

Update on oral antiplatelet therapy: principles, problems and promises

Authors: Grove, Erik L; Kristensen, Steen D

Source: Future Cardiology, Volume 5, Number 3, May 2009 , pp. 247-258(12)

Publisher: Future Medicine

Platelet interactions as therapeutic targets for prevention of atherothrombosis

Authors: Smid, Jan; Braun-Dullaeus, Ruediger; Gawaz, Meinrad; Langer, Harald F

Source: Future Cardiology, Volume 5, Number 3, May 2009 , pp. 285-296(12)

Publisher: Future Medicine

Atherothrombosis and oxidative stress: the connection and correlation in diabetes

Authors: Nwose, Ezekiel U.; Jelinek, Herbert F.; Richards, Ross S.; Tinley, Paul; Kerr, Philip G.

Source: Redox Report, Volume 14, Number 2, April 2009 , pp. 55-60(6)

Publisher: Maney Publishing

The ageing endothelium, cardiovascular risk and disease in man

Authors: Versari, Daniele; Daghini, Elena; Virdis, Agostino; Ghiadoni, Lorenzo; Taddei, Stefano

Source: Experimental Physiology, Volume 94, Number 3, March 2009 , pp. 317-321(5)

Publisher: Blackwell Publishing

Endothelial microparticles in diseases

Authors: Chironi, Gilles; Boulanger, Chantal; Simon, Alain; Dignat-George, Françoise; Freyssinet, Jean-Marie; Tedgui, Alain

Source: Cell and Tissue Research, Volume 335, Number 1, January 2009 , pp. 143-151(9)

Publisher: Springer